The same group also identified macrophages as a primary source of IL-10 and that inhibition of IL-10 receptor induced reduction of the breast cancer tumour burden if combined with chemotherapy, with an equivalent effect caused by blockade of CSF-1R. Here, CSF1R is linked to breast carcinoma.